Locke IC - Search Results

1

The corticotrophin-releasing factor-like peptide urocortin reverses key deficits in two rodent models of Parkinson's disease.

Abuirmeileh A, Lever R, Kingsbury AE, Lees AJ, Locke IC, Knight RA, Chowdrey HS, Biggs CS, Whitton PS. Abuirmeileh A, et al. Among authors: locke ic. Eur J Neurosci. 2007 Jul;26(2):417-23. doi: 10.1111/j.1460-9568.2007.05653.x. Eur J Neurosci. 2007. PMID: 17650114

2

Urocortin protects chondrocytes from NO-induced apoptosis: a future therapy for osteoarthritis?

Intekhab-Alam NY, White OB, Getting SJ, Petsa A, Knight RA, Chowdrey HS, Townsend PA, Lawrence KM, Locke IC. Intekhab-Alam NY, et al. Among authors: locke ic. Cell Death Dis. 2013 Jul 11;4(7):e717. doi: 10.1038/cddis.2013.231. Cell Death Dis. 2013. PMID: 23846219 Free PMC article.

3

Interactions between cell surface protein disulphide isomerase and S-nitrosoglutathione during nitric oxide delivery.

Shah CM, Bell SE, Locke IC, Chowdrey HS, Gordge MP. Shah CM, et al. Among authors: locke ic. Nitric Oxide. 2007 Feb;16(1):135-42. doi: 10.1016/j.niox.2006.08.001. Epub 2006 Aug 11. Nitric Oxide. 2007. PMID: 16990041

4

Rapid S-nitrosothiol metabolism by platelets and megakaryocytes.

Shah CM, Locke IC, Chowdrey HS, Gordge MP. Shah CM, et al. Among authors: locke ic. Biochem Soc Trans. 2003 Dec;31(Pt 6):1450-2. doi: 10.1042/bst0311450. Biochem Soc Trans. 2003. PMID: 14641087

5

Urocortin--from Parkinson's disease to the skeleton.

Lawrence KM, Jackson TR, Jamieson D, Stevens A, Owens G, Sayan BS, Locke IC, Townsend PA. Lawrence KM, et al. Among authors: locke ic. Int J Biochem Cell Biol. 2015 Mar;60:130-8. doi: 10.1016/j.biocel.2014.12.005. Epub 2014 Dec 23. Int J Biochem Cell Biol. 2015. PMID: 25541373 Review.

6

Urocortin is a novel regulator of osteoclast differentiation and function through inhibition of a canonical transient receptor potential 1-like cation channel.

Combs CE, Fuller K, Kumar H, Albert AP, Pirianov G, McCormick J, Locke IC, Chambers TJ, Lawrence KM. Combs CE, et al. Among authors: locke ic. J Endocrinol. 2012 Feb;212(2):187-97. doi: 10.1530/JOE-11-0254. Epub 2011 Nov 14. J Endocrinol. 2012. PMID: 22083217

7

Novel anti-inflammatory and chondroprotective effects of the human melanocortin MC1 receptor agonist BMS-470539 dihydrochloride and human melanocortin MC3 receptor agonist PG-990 on lipopolysaccharide activated chondrocytes.

Can VC, Locke IC, Kaneva MK, Kerrigan MJP, Merlino F, De Pascale C, Grieco P, Getting SJ. Can VC, et al. Among authors: locke ic. Eur J Pharmacol. 2020 Apr 5;872:172971. doi: 10.1016/j.ejphar.2020.172971. Epub 2020 Jan 28. Eur J Pharmacol. 2020. PMID: 32004526

8

Chondroprotective and anti-inflammatory role of melanocortin peptides in TNF-α activated human C-20/A4 chondrocytes.

Kaneva MK, Kerrigan MJ, Grieco P, Curley GP, Locke IC, Getting SJ. Kaneva MK, et al. Among authors: locke ic. Br J Pharmacol. 2012 Sep;167(1):67-79. doi: 10.1111/j.1476-5381.2012.01968.x. Br J Pharmacol. 2012. PMID: 22471953 Free PMC article.

9

Melanocortin peptides protect chondrocytes from mechanically induced cartilage injury.

Kaneva MK, Kerrigan MJ, Grieco P, Curley GP, Locke IC, Getting SJ. Kaneva MK, et al. Among authors: locke ic. Biochem Pharmacol. 2014 Nov 15;92(2):336-47. doi: 10.1016/j.bcp.2014.08.019. Epub 2014 Aug 28. Biochem Pharmacol. 2014. PMID: 25175737

10

Regulation of TNF-Induced Osteoclast Differentiation.

Yao Z, Getting SJ, Locke IC. Yao Z, et al. Among authors: locke ic. Cells. 2021 Dec 31;11(1):132. doi: 10.3390/cells11010132. Cells. 2021. PMID: 35011694 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters